Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Blood Flow Restriction Training in Acute Geriatric Rehabilitation

NCT: NCT07291765 · RECRUITING

NCT IDNCT07291765
StatusRECRUITING
Start Date2026-01-01
Completion2027-03-31

Brief Summary

Background: Older adults have a reduced ability to build and maintain muscle mass due to age-related changes in the muscular system. The resulting sarcopenia can lead to a number of health problems and limitations, such as an increased risk of falling and reduced mobility, which can affect quality of life and increase the risk of disease. To increase muscle mass and strength, high-intensity resistance training with loads of 70 to 85% of the repetition maximum (1RM) is recommended. However, this type of training poses a major challenge in the rehabilitation sector, as there is also an increased risk of injury due to physical limitations in old age. According to current research, low-intensity occlusion training could therefore represent a safe and effective training alternative. The aim of this study is therefore to examine the feasibility and effects of blood flow restriction training (BFR) on general health in older adults in a rehabilitative setting.

Frequently Asked Questions

What is Blood Flow Restriction Training in Acute Geriatric Rehabilitation?

Blood Flow Restriction Training in Acute Geriatric Rehabilitation is a clinical trial registered under NCT07291765. Current status: RECRUITING.

What is the status of NCT07291765?

The current status of NCT07291765 (Blood Flow Restriction Training in Acute Geriatric Rehabilitation) is: RECRUITING.

When did Blood Flow Restriction Training in Acute Geriatric Rehabilitation start?

Blood Flow Restriction Training in Acute Geriatric Rehabilitation started on 2026-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.